data_5ui6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5ui6 _Structure_validation_residue.Date_analyzed 2017-02-03 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 1.346 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.489 -0.244 . . . . 52.4 112.489 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.3 -105.22 0.25 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.745 -0.74 . . . . 64.43 112.498 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -173.24 125.86 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 74.22 110.924 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.84 -169.33 42.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 72.11 112.52 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -42.7 3.13 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.658 2.239 . . . . 63.53 112.321 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.1 mt -82.64 134.14 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 74.54 111.148 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.65 3.43 44.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.13 110.86 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 1.346 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.14 128.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 72.02 110.877 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.4 p -109.57 68.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 73.01 111.173 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -174.49 -34.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 74.54 110.918 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.9 m -75.06 -32.95 27.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.436 . . . . 75.55 111.148 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.19 41.36 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 74.55 111.141 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -120.1 -37.02 3.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 74.4 110.9 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.48 67.1 0.16 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 71.31 112.469 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -151.16 -175.44 5.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 74.32 110.877 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.73 -176.19 4.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 70.31 110.982 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -171.99 -35.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.484 . . . . 71.01 110.939 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.71 -0.757 . . . . 73.12 112.464 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 1.348 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.484 -0.246 . . . . 65.44 112.484 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.63 -105.25 0.25 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.764 -0.731 . . . . 71.22 112.478 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.15 125.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 74.51 110.89 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.91 -169.34 42.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 54.31 112.498 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -42.77 3.11 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 75.11 112.351 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.54 134.16 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.32 111.173 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.72 3.45 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 74.01 110.834 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 1.348 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.14 128.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 73.22 110.879 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.71 68.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.33 111.148 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -174.44 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 72.12 110.908 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 m -75.02 -33.09 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 71.53 111.131 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.21 41.36 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 64.32 111.167 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -120.22 -36.36 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 71.34 110.838 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 67.21 0.17 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.768 -0.73 . . . . 73.23 112.513 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -151.3 -175.44 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 62.33 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -139.83 -176.23 4.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 74.55 110.914 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.02 -35.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.12 110.922 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.722 -0.751 . . . . 65.52 112.492 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 1.349 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.488 -0.245 . . . . 74.31 112.488 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.18 -105.49 0.26 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.734 -0.746 . . . . 61.22 112.509 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -173.04 125.79 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 74.31 110.899 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.95 -169.33 42.37 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 74.21 112.514 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -42.65 3.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 72.43 112.313 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.72 134.1 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.01 111.132 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.626 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.68 3.46 44.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.858 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 1.349 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.3 mt-10 72.17 128.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 73.02 110.931 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.48 68.2 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 74.43 111.149 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -174.48 -34.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 65.44 110.913 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.5 m -75.32 -32.99 26.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 71.2 111.147 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.28 41.27 0.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 75.44 111.141 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -119.8 -37.28 3.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 75.11 110.903 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.85 67.04 0.16 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 74.41 112.524 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -151.34 -175.43 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.827 0.346 . . . . 75.43 110.865 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -139.75 -176.13 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 74.13 110.888 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.01 -35.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 75.11 110.955 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 75.12 112.477 179.939 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 1.365 ' N ' ' OE2' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.468 -0.253 . . . . 75.24 112.468 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.34 -105.4 0.25 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 60.4 112.496 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -173.09 125.82 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 73.5 110.893 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.9 -169.35 42.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.704 -0.76 . . . . 54.35 112.502 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -42.75 3.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.733 2.289 . . . . 74.34 112.363 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.67 134.12 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 74.33 111.087 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.68 3.5 44.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 73.44 110.899 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 1.365 ' OE2' ' N ' ' A' ' 1' ' ' GLY . 26.4 mt-10 72.19 128.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.25 110.883 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.54 68.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 75.45 111.113 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -174.53 -34.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.256 -0.429 . . . . 74.22 110.959 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 m -75.16 -32.98 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 73.4 111.138 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.16 41.43 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 64.33 111.147 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -120.16 -37.01 3.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 73.11 110.86 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.51 67.32 0.16 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.707 -0.759 . . . . 52.22 112.482 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -151.49 -175.39 5.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.887 0.375 . . . . 75.21 110.86 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -139.83 -176.15 4.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 73.23 110.918 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.07 -35.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 71.43 110.871 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 C-N-CA 120.768 -0.73 . . . . 55.24 112.485 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 1.342 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.473 -0.251 . . . . 51.42 112.473 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.41 -105.14 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 72.33 112.489 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.3 125.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.874 0.369 . . . . 74.13 110.863 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.81 -169.32 42.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 74.22 112.503 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -42.72 3.13 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.687 2.258 . . . . 73.43 112.379 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.1 mt -82.68 134.25 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 71.01 111.115 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.627 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.83 3.51 45.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 74.11 110.862 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 1.342 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.2 mt-10 72.14 128.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 71.32 110.922 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.67 68.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 75.53 111.129 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -174.45 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 75.21 110.905 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 12' ' ' THR . 4.8 m -75.0 -33.22 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 73.21 111.124 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 11' ' ' VAL . 8.8 t 38.25 41.38 0.41 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 72.43 111.103 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -120.3 -36.16 3.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.434 . . . . 72.44 110.872 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.67 67.74 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 75.54 112.538 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -151.95 -175.48 5.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 72.35 110.916 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -139.82 -176.24 4.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 70.21 110.901 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -171.97 -35.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 74.24 110.964 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.772 -0.728 . . . . 74.14 112.506 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 1.354 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.508 -0.237 . . . . 72.11 112.508 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.5 -104.95 0.24 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 73.51 112.52 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.37 125.93 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 72.34 110.92 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.83 -169.27 42.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 74.23 112.477 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -42.84 3.07 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.702 2.268 . . . . 65.5 112.355 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.7 mt -82.71 134.25 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 74.41 111.107 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.73 3.44 44.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 74.11 110.855 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 1.354 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.09 128.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 74.2 110.917 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.69 68.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 72.15 111.15 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -174.44 -34.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.933 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 m -75.15 -33.23 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 74.35 111.147 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.15 41.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 73.02 111.109 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.1 -36.48 3.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 64.44 110.895 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.1 67.74 0.17 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.744 -0.741 . . . . 74.34 112.495 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -152.26 -175.58 5.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 75.04 110.908 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -139.65 -176.02 4.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 75.51 110.927 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -172.04 -35.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 74.21 110.948 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 61.23 112.47 179.952 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 1.354 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.523 -0.231 . . . . 71.43 112.523 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.33 -105.44 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 73.42 112.468 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -173.12 125.77 0.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 75.45 110.893 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.89 -169.29 42.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.769 -0.729 . . . . 75.01 112.503 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -42.77 3.11 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.672 2.248 . . . . 74.14 112.347 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.1 mt -82.62 134.12 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 73.33 111.135 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.73 3.46 44.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 73.24 110.846 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 1.354 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.3 mt-10 72.23 128.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.94 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.54 68.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 75.44 111.111 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.2 p90 -174.5 -34.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.244 -0.434 . . . . 72.45 110.933 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 m -75.07 -33.14 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.144 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.14 41.48 0.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 62.21 111.137 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -120.29 -36.29 3.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 71.15 110.86 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 67.85 0.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.74 . . . . 53.1 112.474 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -152.17 -175.48 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 72.23 110.876 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -139.78 -176.11 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 74.35 110.905 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.1 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 71.13 110.954 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 72.25 112.473 179.936 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 1.352 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.452 -0.259 . . . . 71.24 112.452 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.55 -104.91 0.24 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.756 -0.735 . . . . 73.43 112.508 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -173.49 125.88 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 72.3 110.88 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.86 -169.19 42.23 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 74.52 112.484 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -42.89 3.0 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.73 2.287 . . . . 74.13 112.33 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.7 mt -82.71 134.29 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 73.2 111.131 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.77 3.44 45.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.922 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 1.352 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.2 mt-10 72.21 128.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 64.35 110.867 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.71 68.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 55.22 111.14 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.4 p90 -174.49 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 75.5 110.905 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.5 m -75.16 -33.31 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 74.35 111.118 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.17 41.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 73.24 111.131 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -120.03 -36.55 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 71.43 110.885 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.25 68.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.708 -0.758 . . . . 75.34 112.475 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -152.74 -175.69 5.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 72.33 110.854 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -139.54 -175.94 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 75.42 110.942 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.01 -35.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 73.42 110.922 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 63.54 112.514 179.98 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 1.343 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.469 -0.252 . . . . 75.52 112.469 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.44 -105.31 0.25 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 65.05 112.457 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.1 125.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 73.52 110.887 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.85 -169.35 42.35 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.705 -0.76 . . . . 73.21 112.448 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -42.8 3.09 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.728 2.285 . . . . 72.21 112.297 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.9 mt -82.61 134.11 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 74.11 111.143 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.623 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.66 3.48 44.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 74.13 110.86 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 1.343 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.15 128.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 75.15 110.913 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.6 68.1 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 75.25 111.109 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.4 p90 -174.46 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.265 -0.425 . . . . 74.23 110.95 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.7 m -75.08 -33.07 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 73.52 111.149 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.12 41.47 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 75.43 111.171 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -120.12 -36.81 3.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 74.41 110.831 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.3 67.3 0.17 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.748 -0.739 . . . . 71.4 112.522 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -151.61 -175.46 5.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 72.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -139.74 -176.1 4.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.939 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.15 -35.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 64.04 110.918 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.741 -0.743 . . . . 72.04 112.484 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 1.339 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.498 -0.241 . . . . 75.25 112.498 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.0 -105.79 0.26 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 73.31 112.441 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.84 125.84 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.356 . . . . 74.5 110.866 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.95 -169.47 42.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 70.54 112.518 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -42.44 3.42 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.702 2.268 . . . . 73.12 112.333 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.0 mt -82.89 134.08 27.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 71.33 111.158 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.71 3.54 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 73.21 110.894 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 1.339 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.5 mt-10 72.23 128.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 55.01 110.908 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.1 p -109.49 68.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 75.05 111.129 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.4 p90 -174.49 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.442 . . . . 73.34 110.93 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 m -75.31 -33.03 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 73.02 111.125 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.19 41.38 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 70.31 111.156 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -119.83 -37.23 3.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 73.53 110.927 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.74 67.27 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.77 -0.729 . . . . 62.31 112.486 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -151.53 -175.35 5.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 62.23 110.842 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -139.78 -176.04 4.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 73.14 110.906 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.21 -35.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 65.34 110.863 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 75.13 112.485 179.926 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 1.346 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.489 -0.244 . . . . 52.4 112.489 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.3 -105.22 0.25 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.745 -0.74 . . . . 64.43 112.498 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -173.24 125.86 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 74.22 110.924 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.84 -169.33 42.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 72.11 112.52 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -42.7 3.13 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.658 2.239 . . . . 63.53 112.321 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.1 mt -82.64 134.14 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 74.54 111.148 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.65 3.43 44.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.13 110.86 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 1.346 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.14 128.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 72.02 110.877 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.4 p -109.57 68.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 73.01 111.173 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -174.49 -34.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 74.54 110.918 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.9 m -75.06 -32.95 27.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.436 . . . . 75.55 111.148 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.19 41.36 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 74.55 111.141 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -120.1 -37.02 3.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 74.4 110.9 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.48 67.1 0.16 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 71.31 112.469 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -151.16 -175.44 5.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 74.32 110.877 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.73 -176.19 4.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 70.31 110.982 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -171.99 -35.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.484 . . . . 71.01 110.939 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.71 -0.757 . . . . 73.12 112.464 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 1.348 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.484 -0.246 . . . . 65.44 112.484 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.63 -105.25 0.25 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.764 -0.731 . . . . 71.22 112.478 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.15 125.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 74.51 110.89 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.91 -169.34 42.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 54.31 112.498 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -42.77 3.11 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 75.11 112.351 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.54 134.16 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.32 111.173 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.72 3.45 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 74.01 110.834 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 1.348 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.14 128.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 73.22 110.879 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.71 68.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.33 111.148 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -174.44 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 72.12 110.908 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 m -75.02 -33.09 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 71.53 111.131 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.21 41.36 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 64.32 111.167 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -120.22 -36.36 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 71.34 110.838 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 67.21 0.17 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.768 -0.73 . . . . 73.23 112.513 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -151.3 -175.44 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 62.33 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -139.83 -176.23 4.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 74.55 110.914 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.02 -35.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.12 110.922 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.722 -0.751 . . . . 65.52 112.492 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 1.349 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.488 -0.245 . . . . 74.31 112.488 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.18 -105.49 0.26 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.734 -0.746 . . . . 61.22 112.509 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -173.04 125.79 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 74.31 110.899 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.95 -169.33 42.37 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 74.21 112.514 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -42.65 3.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 72.43 112.313 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.72 134.1 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.01 111.132 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.626 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.68 3.46 44.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.858 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 1.349 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.3 mt-10 72.17 128.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 73.02 110.931 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.48 68.2 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 74.43 111.149 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -174.48 -34.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 65.44 110.913 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.5 m -75.32 -32.99 26.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 71.2 111.147 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.28 41.27 0.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 75.44 111.141 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -119.8 -37.28 3.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 75.11 110.903 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.85 67.04 0.16 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 74.41 112.524 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -151.34 -175.43 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.827 0.346 . . . . 75.43 110.865 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -139.75 -176.13 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 74.13 110.888 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.01 -35.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 75.11 110.955 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 75.12 112.477 179.939 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 1.365 ' N ' ' OE2' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.468 -0.253 . . . . 75.24 112.468 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.34 -105.4 0.25 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 60.4 112.496 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -173.09 125.82 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 73.5 110.893 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.9 -169.35 42.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.704 -0.76 . . . . 54.35 112.502 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -42.75 3.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.733 2.289 . . . . 74.34 112.363 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.67 134.12 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 74.33 111.087 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.68 3.5 44.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 73.44 110.899 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 1.365 ' OE2' ' N ' ' A' ' 1' ' ' GLY . 26.4 mt-10 72.19 128.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.25 110.883 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.54 68.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 75.45 111.113 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -174.53 -34.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.256 -0.429 . . . . 74.22 110.959 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 m -75.16 -32.98 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 73.4 111.138 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.16 41.43 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 64.33 111.147 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -120.16 -37.01 3.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 73.11 110.86 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.51 67.32 0.16 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.707 -0.759 . . . . 52.22 112.482 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -151.49 -175.39 5.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.887 0.375 . . . . 75.21 110.86 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -139.83 -176.15 4.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 73.23 110.918 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.07 -35.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 71.43 110.871 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 C-N-CA 120.768 -0.73 . . . . 55.24 112.485 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 1.342 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.473 -0.251 . . . . 51.42 112.473 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.41 -105.14 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 72.33 112.489 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.3 125.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.874 0.369 . . . . 74.13 110.863 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.81 -169.32 42.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 74.22 112.503 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -42.72 3.13 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.687 2.258 . . . . 73.43 112.379 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.1 mt -82.68 134.25 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 71.01 111.115 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.627 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.83 3.51 45.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 74.11 110.862 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 1.342 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.2 mt-10 72.14 128.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 71.32 110.922 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.67 68.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 75.53 111.129 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -174.45 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 75.21 110.905 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 12' ' ' THR . 4.8 m -75.0 -33.22 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 73.21 111.124 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 11' ' ' VAL . 8.8 t 38.25 41.38 0.41 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 72.43 111.103 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -120.3 -36.16 3.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.434 . . . . 72.44 110.872 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.67 67.74 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 75.54 112.538 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -151.95 -175.48 5.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 72.35 110.916 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -139.82 -176.24 4.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 70.21 110.901 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -171.97 -35.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 74.24 110.964 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.772 -0.728 . . . . 74.14 112.506 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 1.354 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.508 -0.237 . . . . 72.11 112.508 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.5 -104.95 0.24 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 73.51 112.52 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.37 125.93 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 72.34 110.92 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.83 -169.27 42.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 74.23 112.477 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -42.84 3.07 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.702 2.268 . . . . 65.5 112.355 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.7 mt -82.71 134.25 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 74.41 111.107 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.73 3.44 44.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 74.11 110.855 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 1.354 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.09 128.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 74.2 110.917 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.69 68.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 72.15 111.15 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -174.44 -34.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.933 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 m -75.15 -33.23 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 74.35 111.147 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.15 41.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 73.02 111.109 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.1 -36.48 3.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 64.44 110.895 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.1 67.74 0.17 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.744 -0.741 . . . . 74.34 112.495 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -152.26 -175.58 5.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 75.04 110.908 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -139.65 -176.02 4.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 75.51 110.927 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -172.04 -35.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 74.21 110.948 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 61.23 112.47 179.952 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 1.354 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.523 -0.231 . . . . 71.43 112.523 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.33 -105.44 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 73.42 112.468 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -173.12 125.77 0.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 75.45 110.893 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.89 -169.29 42.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.769 -0.729 . . . . 75.01 112.503 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -42.77 3.11 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.672 2.248 . . . . 74.14 112.347 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.1 mt -82.62 134.12 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 73.33 111.135 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.73 3.46 44.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 73.24 110.846 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 1.354 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.3 mt-10 72.23 128.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.94 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.54 68.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 75.44 111.111 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.2 p90 -174.5 -34.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.244 -0.434 . . . . 72.45 110.933 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 m -75.07 -33.14 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.144 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.14 41.48 0.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 62.21 111.137 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -120.29 -36.29 3.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 71.15 110.86 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 67.85 0.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.74 . . . . 53.1 112.474 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -152.17 -175.48 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 72.23 110.876 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -139.78 -176.11 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 74.35 110.905 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.1 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 71.13 110.954 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 72.25 112.473 179.936 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 1.352 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.452 -0.259 . . . . 71.24 112.452 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.55 -104.91 0.24 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.756 -0.735 . . . . 73.43 112.508 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -173.49 125.88 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 72.3 110.88 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.86 -169.19 42.23 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 74.52 112.484 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -42.89 3.0 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.73 2.287 . . . . 74.13 112.33 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.7 mt -82.71 134.29 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 73.2 111.131 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.77 3.44 45.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.922 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 1.352 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.2 mt-10 72.21 128.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 64.35 110.867 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.71 68.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 55.22 111.14 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.4 p90 -174.49 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 75.5 110.905 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.5 m -75.16 -33.31 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 74.35 111.118 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.17 41.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 73.24 111.131 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -120.03 -36.55 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 71.43 110.885 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.25 68.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.708 -0.758 . . . . 75.34 112.475 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -152.74 -175.69 5.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 72.33 110.854 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -139.54 -175.94 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 75.42 110.942 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.01 -35.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 73.42 110.922 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 63.54 112.514 179.98 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 1.343 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.469 -0.252 . . . . 75.52 112.469 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.44 -105.31 0.25 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 65.05 112.457 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.1 125.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 73.52 110.887 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.85 -169.35 42.35 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.705 -0.76 . . . . 73.21 112.448 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -42.8 3.09 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.728 2.285 . . . . 72.21 112.297 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.9 mt -82.61 134.11 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 74.11 111.143 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.623 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.66 3.48 44.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 74.13 110.86 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 1.343 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.15 128.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 75.15 110.913 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.6 68.1 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 75.25 111.109 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.4 p90 -174.46 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.265 -0.425 . . . . 74.23 110.95 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.7 m -75.08 -33.07 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 73.52 111.149 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.12 41.47 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 75.43 111.171 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -120.12 -36.81 3.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 74.41 110.831 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.3 67.3 0.17 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.748 -0.739 . . . . 71.4 112.522 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -151.61 -175.46 5.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 72.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -139.74 -176.1 4.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.939 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.15 -35.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 64.04 110.918 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.741 -0.743 . . . . 72.04 112.484 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 1.339 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.498 -0.241 . . . . 75.25 112.498 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.0 -105.79 0.26 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 73.31 112.441 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.84 125.84 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.356 . . . . 74.5 110.866 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.95 -169.47 42.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 70.54 112.518 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -42.44 3.42 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.702 2.268 . . . . 73.12 112.333 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.0 mt -82.89 134.08 27.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 71.33 111.158 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.71 3.54 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 73.21 110.894 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 1.339 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.5 mt-10 72.23 128.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 55.01 110.908 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.1 p -109.49 68.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 75.05 111.129 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.4 p90 -174.49 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.442 . . . . 73.34 110.93 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.6 m -75.31 -33.03 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 73.02 111.125 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.19 41.38 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 70.31 111.156 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -119.83 -37.23 3.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 73.53 110.927 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.74 67.27 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.77 -0.729 . . . . 62.31 112.486 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -151.53 -175.35 5.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 62.23 110.842 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -139.78 -176.04 4.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 73.14 110.906 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.21 -35.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 65.34 110.863 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 75.13 112.485 179.926 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 1.346 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.489 -0.244 . . . . 45.03 112.489 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.3 -105.22 0.25 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.745 -0.74 . . . . 64.42 112.498 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -173.24 125.86 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 72.44 110.924 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.84 -169.33 42.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 72.11 112.52 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -42.7 3.13 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.658 2.239 . . . . 53.42 112.321 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.802 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.1 mt -82.64 134.14 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 74.13 111.148 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.65 3.43 44.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.13 110.86 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.346 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.14 128.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 72.02 110.877 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.4 p -109.57 68.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 63.22 111.173 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.737 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.49 -34.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 72.31 110.918 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.737 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.9 m -75.06 -32.95 27.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.436 . . . . 75.55 111.148 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.19 41.36 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 70.25 111.141 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -120.1 -37.02 3.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 74.4 110.9 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.48 67.1 0.16 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 71.31 112.469 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -151.16 -175.44 5.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 74.32 110.877 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.73 -176.19 4.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 65.33 110.982 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -171.99 -35.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.484 . . . . 70.32 110.939 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.519 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.71 -0.757 . . . . 65.31 112.464 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 1.348 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.484 -0.246 . . . . 65.44 112.484 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.63 -105.25 0.25 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.764 -0.731 . . . . 71.22 112.478 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.15 125.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 71.05 110.89 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.91 -169.34 42.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 54.31 112.498 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -42.77 3.11 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 43.11 112.351 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.803 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.3 mt -82.54 134.16 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.32 111.173 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.72 3.45 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 63.2 110.834 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.348 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.14 128.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 72.45 110.879 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.71 68.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 71.01 111.148 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.74 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.44 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 72.12 110.908 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.74 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.6 m -75.02 -33.09 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 71.53 111.131 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.21 41.36 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 64.24 111.167 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -120.22 -36.36 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 71.34 110.838 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 67.21 0.17 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.768 -0.73 . . . . 63.24 112.513 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -151.3 -175.44 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 54.34 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -139.83 -176.23 4.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 74.55 110.914 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.02 -35.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.12 110.922 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.519 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.722 -0.751 . . . . 65.52 112.492 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 1.349 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.488 -0.245 . . . . 60.41 112.488 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.18 -105.49 0.26 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.734 -0.746 . . . . 61.22 112.509 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -173.04 125.79 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 72.13 110.899 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.95 -169.33 42.37 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 74.21 112.514 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -42.65 3.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 72.43 112.313 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.3 mt -82.72 134.1 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.01 111.132 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.626 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.68 3.46 44.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.858 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.349 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.3 mt-10 72.17 128.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 71.0 110.931 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.48 68.2 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 74.43 111.149 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.743 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.48 -34.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 63.22 110.913 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.743 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.5 m -75.32 -32.99 26.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 64.32 111.147 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.28 41.27 0.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 75.44 111.141 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -119.8 -37.28 3.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 65.03 110.903 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.85 67.04 0.16 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 74.41 112.524 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -151.34 -175.43 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.827 0.346 . . . . 64.34 110.865 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -139.75 -176.13 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 71.54 110.888 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.01 -35.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 75.11 110.955 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.521 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 60.31 112.477 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 1.355 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.468 -0.253 . . . . 75.24 112.468 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.34 -105.4 0.25 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 41.32 112.496 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -173.09 125.82 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 73.5 110.893 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.9 -169.35 42.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.704 -0.76 . . . . 31.43 112.502 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -42.75 3.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.733 2.289 . . . . 74.34 112.363 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.786 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.3 mt -82.67 134.12 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 61.51 111.087 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.68 3.5 44.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 61.42 110.899 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.355 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.4 mt-10 72.19 128.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.25 110.883 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.54 68.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 75.45 111.113 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.736 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.53 -34.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.256 -0.429 . . . . 74.22 110.959 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.736 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.8 m -75.16 -32.98 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 71.13 111.138 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.16 41.43 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 64.33 111.147 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -120.16 -37.01 3.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 73.11 110.86 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.51 67.32 0.16 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.707 -0.759 . . . . 44.24 112.482 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -151.49 -175.39 5.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.887 0.375 . . . . 75.21 110.86 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -139.83 -176.15 4.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 73.23 110.918 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.07 -35.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 71.43 110.871 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.527 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.368 0 C-N-CA 120.768 -0.73 . . . . 55.24 112.485 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 1.342 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.473 -0.251 . . . . 51.42 112.473 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.41 -105.14 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 72.33 112.489 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.3 125.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.874 0.369 . . . . 71.41 110.863 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.81 -169.32 42.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 74.22 112.503 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -42.72 3.13 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.687 2.258 . . . . 71.32 112.379 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.1 mt -82.68 134.25 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 65.14 111.115 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.627 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.83 3.51 45.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 72.11 110.862 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.342 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.2 mt-10 72.14 128.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 65.32 110.922 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.67 68.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 75.53 111.129 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.739 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.45 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 75.21 110.905 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.739 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.8 m -75.0 -33.22 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 71.44 111.124 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 11' ' ' VAL . 8.8 t 38.25 41.38 0.41 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 62.44 111.103 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -120.3 -36.16 3.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.434 . . . . 72.44 110.872 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.67 67.74 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 62.41 112.538 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -151.95 -175.48 5.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 72.35 110.916 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -139.82 -176.24 4.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 70.21 110.901 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -171.97 -35.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 74.24 110.964 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.772 -0.728 . . . . 74.14 112.506 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 1.354 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.508 -0.237 . . . . 72.11 112.508 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.5 -104.95 0.24 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 71.32 112.52 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.37 125.93 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 63.21 110.92 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.83 -169.27 42.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 74.23 112.477 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -42.84 3.07 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.702 2.268 . . . . 65.5 112.355 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.798 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.7 mt -82.71 134.25 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 60.34 111.107 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.73 3.44 44.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 74.11 110.855 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.354 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.09 128.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 74.2 110.917 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.69 68.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 71.34 111.15 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.741 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.0 p90 -174.44 -34.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.933 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.741 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.6 m -75.15 -33.23 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 54.41 111.147 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.15 41.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 44.32 111.109 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.1 -36.48 3.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 64.44 110.895 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.1 67.74 0.17 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.744 -0.741 . . . . 60.2 112.495 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -152.26 -175.58 5.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 72.51 110.908 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -139.65 -176.02 4.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 75.51 110.927 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -172.04 -35.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.2 110.948 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.529 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 61.23 112.47 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 1.354 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.523 -0.231 . . . . 71.43 112.523 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.33 -105.44 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 73.42 112.468 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -173.12 125.77 0.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 74.02 110.893 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.89 -169.29 42.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.769 -0.729 . . . . 75.01 112.503 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -42.77 3.11 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.672 2.248 . . . . 74.14 112.347 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.795 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.1 mt -82.62 134.12 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 73.33 111.135 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.73 3.46 44.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 73.24 110.846 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.354 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.3 mt-10 72.23 128.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.94 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.54 68.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 64.0 111.111 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.739 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.2 p90 -174.5 -34.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.244 -0.434 . . . . 72.45 110.933 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.739 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.6 m -75.07 -33.14 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.144 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.14 41.48 0.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 62.21 111.137 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -120.29 -36.29 3.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 71.15 110.86 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 67.85 0.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.74 . . . . 53.05 112.474 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -152.17 -175.48 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 71.41 110.876 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -139.78 -176.11 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 74.35 110.905 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.1 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 70.45 110.954 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 72.02 112.473 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 1.352 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.452 -0.259 . . . . 64.43 112.452 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.55 -104.91 0.24 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.756 -0.735 . . . . 65.31 112.508 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -173.49 125.88 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 62.54 110.88 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.86 -169.19 42.23 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 74.52 112.484 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -42.89 3.0 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.73 2.287 . . . . 72.14 112.33 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.799 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.7 mt -82.71 134.29 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 73.2 111.131 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.77 3.44 45.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.922 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.352 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.2 mt-10 72.21 128.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 64.35 110.867 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.71 68.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 55.22 111.14 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.742 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.4 p90 -174.49 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 73.21 110.905 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.742 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.5 m -75.16 -33.31 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 74.35 111.118 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.17 41.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 73.23 111.131 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -120.03 -36.55 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 71.43 110.885 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.25 68.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.708 -0.758 . . . . 75.34 112.475 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -152.74 -175.69 5.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 64.52 110.854 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -139.54 -175.94 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 75.42 110.942 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.01 -35.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 73.42 110.922 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.529 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 51.2 112.514 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 1.343 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.469 -0.252 . . . . 75.52 112.469 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.44 -105.31 0.25 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 65.05 112.457 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.1 125.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 63.51 110.887 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.85 -169.35 42.35 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.705 -0.76 . . . . 73.21 112.448 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -42.8 3.09 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.728 2.285 . . . . 72.21 112.297 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.808 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.9 mt -82.61 134.11 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 74.11 111.143 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.623 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.66 3.48 44.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 73.01 110.86 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.343 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.15 128.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 63.12 110.913 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.6 68.1 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 75.25 111.109 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.74 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.4 p90 -174.46 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.265 -0.425 . . . . 71.32 110.95 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.74 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.7 m -75.08 -33.07 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 61.02 111.149 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.12 41.47 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 64.13 111.171 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -120.12 -36.81 3.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 74.41 110.831 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.3 67.3 0.17 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.748 -0.739 . . . . 71.4 112.522 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -151.61 -175.46 5.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 72.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -139.74 -176.1 4.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.939 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.15 -35.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 63.21 110.918 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.53 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.741 -0.743 . . . . 61.44 112.484 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 1.339 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.498 -0.241 . . . . 64.32 112.498 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.0 -105.79 0.26 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 71.22 112.441 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.84 125.84 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.356 . . . . 72.22 110.866 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.95 -169.47 42.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 70.54 112.518 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -42.44 3.42 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.702 2.268 . . . . 73.12 112.333 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.807 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.0 mt -82.89 134.08 27.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 71.33 111.158 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.71 3.54 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 61.11 110.894 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.339 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.5 mt-10 72.23 128.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 55.01 110.908 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.1 p -109.49 68.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 71.02 111.129 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.739 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.4 p90 -174.49 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.442 . . . . 73.01 110.93 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.739 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.6 m -75.31 -33.03 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 71.44 111.125 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.19 41.38 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 44.32 111.156 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -119.83 -37.23 3.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 73.53 110.927 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.74 67.27 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.77 -0.729 . . . . 53.34 112.486 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -151.53 -175.35 5.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 62.23 110.842 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -139.78 -176.04 4.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 73.14 110.906 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.21 -35.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 65.34 110.863 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.517 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 75.13 112.485 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 1.346 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.489 -0.244 . . . . 45.03 112.489 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.3 -105.22 0.25 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.745 -0.74 . . . . 64.42 112.498 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -173.24 125.86 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 72.44 110.924 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.84 -169.33 42.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 72.11 112.52 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -42.7 3.13 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.658 2.239 . . . . 53.42 112.321 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.802 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.1 mt -82.64 134.14 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 74.13 111.148 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.65 3.43 44.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.13 110.86 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.346 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.14 128.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 72.02 110.877 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.4 p -109.57 68.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 63.22 111.173 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.737 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.49 -34.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 72.31 110.918 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.737 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.9 m -75.06 -32.95 27.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.436 . . . . 75.55 111.148 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.19 41.36 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 70.25 111.141 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -120.1 -37.02 3.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 74.4 110.9 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.48 67.1 0.16 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 71.31 112.469 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -151.16 -175.44 5.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 74.32 110.877 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.73 -176.19 4.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 65.33 110.982 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -171.99 -35.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.484 . . . . 70.32 110.939 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.519 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.71 -0.757 . . . . 65.31 112.464 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 1.348 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.484 -0.246 . . . . 65.44 112.484 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.63 -105.25 0.25 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.764 -0.731 . . . . 71.22 112.478 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.15 125.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 71.05 110.89 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.91 -169.34 42.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 54.31 112.498 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -42.77 3.11 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 43.11 112.351 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.803 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.3 mt -82.54 134.16 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.32 111.173 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.72 3.45 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 63.2 110.834 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.348 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.14 128.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 72.45 110.879 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.71 68.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 71.01 111.148 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.74 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.44 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 72.12 110.908 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.74 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.6 m -75.02 -33.09 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 71.53 111.131 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.21 41.36 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 64.24 111.167 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -120.22 -36.36 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 71.34 110.838 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 67.21 0.17 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.768 -0.73 . . . . 63.24 112.513 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -151.3 -175.44 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 54.34 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -139.83 -176.23 4.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 74.55 110.914 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.02 -35.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.12 110.922 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.519 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.722 -0.751 . . . . 65.52 112.492 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 1.349 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.488 -0.245 . . . . 60.41 112.488 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.18 -105.49 0.26 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.734 -0.746 . . . . 61.22 112.509 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -173.04 125.79 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 72.13 110.899 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.95 -169.33 42.37 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 74.21 112.514 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -42.65 3.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 72.43 112.313 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.3 mt -82.72 134.1 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.01 111.132 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.626 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.68 3.46 44.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.858 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.349 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.3 mt-10 72.17 128.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 71.0 110.931 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.48 68.2 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 74.43 111.149 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.743 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.48 -34.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 63.22 110.913 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.743 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.5 m -75.32 -32.99 26.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 64.32 111.147 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.28 41.27 0.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 75.44 111.141 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -119.8 -37.28 3.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 65.03 110.903 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.85 67.04 0.16 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 74.41 112.524 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -151.34 -175.43 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.827 0.346 . . . . 64.34 110.865 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -139.75 -176.13 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 71.54 110.888 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.01 -35.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 75.11 110.955 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.521 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 60.31 112.477 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 1.355 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.468 -0.253 . . . . 75.24 112.468 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.34 -105.4 0.25 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 41.32 112.496 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -173.09 125.82 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 73.5 110.893 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.9 -169.35 42.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.704 -0.76 . . . . 31.43 112.502 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -42.75 3.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.733 2.289 . . . . 74.34 112.363 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.786 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.3 mt -82.67 134.12 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 61.51 111.087 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.68 3.5 44.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 61.42 110.899 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.355 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.4 mt-10 72.19 128.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.25 110.883 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.54 68.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 75.45 111.113 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.736 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.53 -34.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.256 -0.429 . . . . 74.22 110.959 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.736 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.8 m -75.16 -32.98 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 71.13 111.138 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.16 41.43 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 64.33 111.147 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -120.16 -37.01 3.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 73.11 110.86 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.51 67.32 0.16 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.707 -0.759 . . . . 44.24 112.482 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -151.49 -175.39 5.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.887 0.375 . . . . 75.21 110.86 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -139.83 -176.15 4.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 73.23 110.918 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.07 -35.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 71.43 110.871 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.527 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.368 0 C-N-CA 120.768 -0.73 . . . . 55.24 112.485 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 1.342 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.473 -0.251 . . . . 51.42 112.473 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.41 -105.14 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 72.33 112.489 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.3 125.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.874 0.369 . . . . 71.41 110.863 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.81 -169.32 42.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 74.22 112.503 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -42.72 3.13 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.687 2.258 . . . . 71.32 112.379 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.1 mt -82.68 134.25 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 65.14 111.115 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.627 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.83 3.51 45.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 72.11 110.862 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.342 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.2 mt-10 72.14 128.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 65.32 110.922 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.67 68.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 75.53 111.129 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.739 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.45 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 75.21 110.905 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.739 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.8 m -75.0 -33.22 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 71.44 111.124 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 11' ' ' VAL . 8.8 t 38.25 41.38 0.41 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 62.44 111.103 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -120.3 -36.16 3.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.434 . . . . 72.44 110.872 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.67 67.74 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 62.41 112.538 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -151.95 -175.48 5.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 72.35 110.916 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -139.82 -176.24 4.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 70.21 110.901 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -171.97 -35.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 74.24 110.964 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.772 -0.728 . . . . 74.14 112.506 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 1.354 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.508 -0.237 . . . . 72.11 112.508 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.5 -104.95 0.24 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 71.32 112.52 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.37 125.93 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 63.21 110.92 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.83 -169.27 42.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 74.23 112.477 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -42.84 3.07 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.702 2.268 . . . . 65.5 112.355 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.798 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.7 mt -82.71 134.25 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 60.34 111.107 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.73 3.44 44.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 74.11 110.855 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.354 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.09 128.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 74.2 110.917 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.69 68.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 71.34 111.15 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.741 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.0 p90 -174.44 -34.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.933 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.741 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.6 m -75.15 -33.23 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 54.41 111.147 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.15 41.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 44.32 111.109 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.1 -36.48 3.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 64.44 110.895 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.1 67.74 0.17 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.744 -0.741 . . . . 60.2 112.495 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -152.26 -175.58 5.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 72.51 110.908 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -139.65 -176.02 4.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 75.51 110.927 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -172.04 -35.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.2 110.948 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.529 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 61.23 112.47 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 1.354 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.523 -0.231 . . . . 71.43 112.523 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.33 -105.44 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 73.42 112.468 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -173.12 125.77 0.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 74.02 110.893 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.89 -169.29 42.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.769 -0.729 . . . . 75.01 112.503 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -42.77 3.11 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.672 2.248 . . . . 74.14 112.347 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.795 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.1 mt -82.62 134.12 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 73.33 111.135 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.73 3.46 44.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 73.24 110.846 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.354 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.3 mt-10 72.23 128.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.94 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.54 68.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 64.0 111.111 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.739 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.2 p90 -174.5 -34.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.244 -0.434 . . . . 72.45 110.933 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.739 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.6 m -75.07 -33.14 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.144 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.14 41.48 0.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 62.21 111.137 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -120.29 -36.29 3.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 71.15 110.86 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 67.85 0.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.74 . . . . 53.05 112.474 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -152.17 -175.48 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 71.41 110.876 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -139.78 -176.11 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 74.35 110.905 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.1 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 70.45 110.954 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 72.02 112.473 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 1.352 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.452 -0.259 . . . . 64.43 112.452 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.55 -104.91 0.24 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.756 -0.735 . . . . 65.31 112.508 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -173.49 125.88 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 62.54 110.88 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.86 -169.19 42.23 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 74.52 112.484 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -42.89 3.0 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.73 2.287 . . . . 72.14 112.33 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.799 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.7 mt -82.71 134.29 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 73.2 111.131 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.77 3.44 45.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.922 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.352 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.2 mt-10 72.21 128.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 64.35 110.867 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.71 68.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 55.22 111.14 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.742 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.4 p90 -174.49 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 73.21 110.905 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.742 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.5 m -75.16 -33.31 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 74.35 111.118 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.17 41.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 73.23 111.131 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -120.03 -36.55 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 71.43 110.885 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.25 68.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.708 -0.758 . . . . 75.34 112.475 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -152.74 -175.69 5.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 64.52 110.854 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -139.54 -175.94 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 75.42 110.942 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.01 -35.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 73.42 110.922 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.529 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 51.2 112.514 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 1.343 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.469 -0.252 . . . . 75.52 112.469 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.44 -105.31 0.25 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 65.05 112.457 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.1 125.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 63.51 110.887 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.85 -169.35 42.35 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.705 -0.76 . . . . 73.21 112.448 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -42.8 3.09 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.728 2.285 . . . . 72.21 112.297 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.808 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.9 mt -82.61 134.11 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 74.11 111.143 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.623 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.66 3.48 44.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 73.01 110.86 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.343 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.15 128.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 63.12 110.913 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.6 68.1 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 75.25 111.109 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.74 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.4 p90 -174.46 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.265 -0.425 . . . . 71.32 110.95 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.74 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.7 m -75.08 -33.07 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 61.02 111.149 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.12 41.47 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 64.13 111.171 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -120.12 -36.81 3.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 74.41 110.831 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.3 67.3 0.17 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.748 -0.739 . . . . 71.4 112.522 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -151.61 -175.46 5.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 72.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -139.74 -176.1 4.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.939 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.15 -35.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 63.21 110.918 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.53 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.741 -0.743 . . . . 61.44 112.484 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 1.339 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.498 -0.241 . . . . 64.32 112.498 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.0 -105.79 0.26 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 71.22 112.441 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.84 125.84 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.356 . . . . 72.22 110.866 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.95 -169.47 42.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 70.54 112.518 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -42.44 3.42 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.702 2.268 . . . . 73.12 112.333 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.807 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.0 mt -82.89 134.08 27.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 71.33 111.158 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.71 3.54 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 61.11 110.894 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.339 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.5 mt-10 72.23 128.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 55.01 110.908 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.1 p -109.49 68.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 71.02 111.129 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.739 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.4 p90 -174.49 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.442 . . . . 73.01 110.93 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.739 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.6 m -75.31 -33.03 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 71.44 111.125 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.19 41.38 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 44.32 111.156 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -119.83 -37.23 3.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 73.53 110.927 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.74 67.27 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.77 -0.729 . . . . 53.34 112.486 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -151.53 -175.35 5.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 62.23 110.842 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -139.78 -176.04 4.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 73.14 110.906 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.21 -35.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 65.34 110.863 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.517 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 75.13 112.485 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 1.346 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.489 -0.244 . . . . 45.03 112.489 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.3 -105.22 0.25 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.745 -0.74 . . . . 64.42 112.498 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -173.24 125.86 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 72.44 110.924 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.84 -169.33 42.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 72.11 112.52 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -42.7 3.13 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.658 2.239 . . . . 53.42 112.321 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.802 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.1 mt -82.64 134.14 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 74.13 111.148 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.65 3.43 44.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.13 110.86 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.346 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.14 128.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 72.02 110.877 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.4 p -109.57 68.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 63.22 111.173 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.737 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.49 -34.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 72.31 110.918 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.737 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.9 m -75.06 -32.95 27.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.436 . . . . 75.55 111.148 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.19 41.36 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 70.25 111.141 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -120.1 -37.02 3.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 74.4 110.9 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.48 67.1 0.16 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 71.31 112.469 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -151.16 -175.44 5.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 74.32 110.877 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.73 -176.19 4.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 65.33 110.982 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -171.99 -35.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.484 . . . . 70.32 110.939 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.519 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.71 -0.757 . . . . 65.31 112.464 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 1.348 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.484 -0.246 . . . . 65.44 112.484 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.63 -105.25 0.25 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.764 -0.731 . . . . 71.22 112.478 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.15 125.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 71.05 110.89 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.91 -169.34 42.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 54.31 112.498 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -42.77 3.11 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 43.11 112.351 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.803 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.3 mt -82.54 134.16 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.32 111.173 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.72 3.45 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 63.2 110.834 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.348 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.14 128.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 72.45 110.879 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.71 68.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 71.01 111.148 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.74 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.44 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 72.12 110.908 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.74 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.6 m -75.02 -33.09 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 71.53 111.131 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.21 41.36 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 64.24 111.167 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -120.22 -36.36 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 71.34 110.838 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 67.21 0.17 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.768 -0.73 . . . . 63.24 112.513 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -151.3 -175.44 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 54.34 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -139.83 -176.23 4.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 74.55 110.914 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.02 -35.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.12 110.922 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.519 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.722 -0.751 . . . . 65.52 112.492 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 1.349 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.488 -0.245 . . . . 60.41 112.488 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.18 -105.49 0.26 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.734 -0.746 . . . . 61.22 112.509 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -173.04 125.79 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 72.13 110.899 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.95 -169.33 42.37 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 74.21 112.514 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -42.65 3.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 72.43 112.313 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.3 mt -82.72 134.1 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.01 111.132 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.626 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.68 3.46 44.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.858 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.349 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.3 mt-10 72.17 128.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 71.0 110.931 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.48 68.2 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 74.43 111.149 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.743 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.48 -34.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 63.22 110.913 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.743 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.5 m -75.32 -32.99 26.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 64.32 111.147 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.28 41.27 0.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 75.44 111.141 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -119.8 -37.28 3.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 65.03 110.903 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.85 67.04 0.16 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 74.41 112.524 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -151.34 -175.43 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.827 0.346 . . . . 64.34 110.865 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -139.75 -176.13 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 71.54 110.888 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.01 -35.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 75.11 110.955 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.521 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 60.31 112.477 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 1.355 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.468 -0.253 . . . . 75.24 112.468 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.34 -105.4 0.25 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 41.32 112.496 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -173.09 125.82 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 73.5 110.893 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.9 -169.35 42.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.704 -0.76 . . . . 31.43 112.502 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -42.75 3.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.733 2.289 . . . . 74.34 112.363 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.786 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.3 mt -82.67 134.12 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 61.51 111.087 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.68 3.5 44.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 61.42 110.899 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.355 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.4 mt-10 72.19 128.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.25 110.883 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.54 68.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 75.45 111.113 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.736 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.53 -34.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.256 -0.429 . . . . 74.22 110.959 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.736 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.8 m -75.16 -32.98 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 71.13 111.138 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.16 41.43 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 64.33 111.147 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -120.16 -37.01 3.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 73.11 110.86 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.51 67.32 0.16 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.707 -0.759 . . . . 44.24 112.482 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -151.49 -175.39 5.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.887 0.375 . . . . 75.21 110.86 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -139.83 -176.15 4.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 73.23 110.918 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.07 -35.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 71.43 110.871 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.527 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.368 0 C-N-CA 120.768 -0.73 . . . . 55.24 112.485 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 1.342 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.473 -0.251 . . . . 51.42 112.473 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.41 -105.14 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 72.33 112.489 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.3 125.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.874 0.369 . . . . 71.41 110.863 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.81 -169.32 42.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 74.22 112.503 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -42.72 3.13 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.687 2.258 . . . . 71.32 112.379 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.1 mt -82.68 134.25 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 65.14 111.115 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.627 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.83 3.51 45.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 72.11 110.862 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.342 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.2 mt-10 72.14 128.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 65.32 110.922 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.67 68.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 75.53 111.129 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.739 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.45 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 75.21 110.905 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.739 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.8 m -75.0 -33.22 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 71.44 111.124 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 11' ' ' VAL . 8.8 t 38.25 41.38 0.41 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 62.44 111.103 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -120.3 -36.16 3.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.434 . . . . 72.44 110.872 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.67 67.74 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 62.41 112.538 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -151.95 -175.48 5.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 72.35 110.916 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -139.82 -176.24 4.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 70.21 110.901 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -171.97 -35.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 74.24 110.964 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.772 -0.728 . . . . 74.14 112.506 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 1.354 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.508 -0.237 . . . . 72.11 112.508 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.5 -104.95 0.24 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 71.32 112.52 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.37 125.93 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 63.21 110.92 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.83 -169.27 42.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 74.23 112.477 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -42.84 3.07 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.702 2.268 . . . . 65.5 112.355 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.798 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.7 mt -82.71 134.25 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 60.34 111.107 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.73 3.44 44.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 74.11 110.855 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.354 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.09 128.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 74.2 110.917 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.69 68.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 71.34 111.15 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.741 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.0 p90 -174.44 -34.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.933 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.741 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.6 m -75.15 -33.23 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 54.41 111.147 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.15 41.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 44.32 111.109 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.1 -36.48 3.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 64.44 110.895 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.1 67.74 0.17 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.744 -0.741 . . . . 60.2 112.495 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -152.26 -175.58 5.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 72.51 110.908 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -139.65 -176.02 4.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 75.51 110.927 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -172.04 -35.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.2 110.948 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.529 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 61.23 112.47 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 1.354 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.523 -0.231 . . . . 71.43 112.523 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.33 -105.44 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 73.42 112.468 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -173.12 125.77 0.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 74.02 110.893 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.89 -169.29 42.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.769 -0.729 . . . . 75.01 112.503 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -42.77 3.11 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.672 2.248 . . . . 74.14 112.347 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.795 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.1 mt -82.62 134.12 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 73.33 111.135 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.73 3.46 44.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 73.24 110.846 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.354 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.3 mt-10 72.23 128.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.94 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.54 68.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 64.0 111.111 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.739 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.2 p90 -174.5 -34.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.244 -0.434 . . . . 72.45 110.933 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.739 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.6 m -75.07 -33.14 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.144 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.14 41.48 0.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 62.21 111.137 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -120.29 -36.29 3.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 71.15 110.86 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 67.85 0.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.74 . . . . 53.05 112.474 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -152.17 -175.48 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 71.41 110.876 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -139.78 -176.11 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 74.35 110.905 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.1 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 70.45 110.954 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 72.02 112.473 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 1.352 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.452 -0.259 . . . . 64.43 112.452 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.55 -104.91 0.24 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.756 -0.735 . . . . 65.31 112.508 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -173.49 125.88 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 62.54 110.88 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.86 -169.19 42.23 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 74.52 112.484 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -42.89 3.0 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.73 2.287 . . . . 72.14 112.33 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.799 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.7 mt -82.71 134.29 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 73.2 111.131 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.77 3.44 45.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.922 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.352 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.2 mt-10 72.21 128.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 64.35 110.867 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.71 68.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 55.22 111.14 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.742 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.4 p90 -174.49 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 73.21 110.905 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.742 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.5 m -75.16 -33.31 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 74.35 111.118 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.17 41.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 73.23 111.131 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -120.03 -36.55 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 71.43 110.885 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.25 68.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.708 -0.758 . . . . 75.34 112.475 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -152.74 -175.69 5.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 64.52 110.854 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -139.54 -175.94 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 75.42 110.942 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.01 -35.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 73.42 110.922 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.529 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 51.2 112.514 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 1.343 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.469 -0.252 . . . . 75.52 112.469 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.44 -105.31 0.25 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 65.05 112.457 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.1 125.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 63.51 110.887 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.85 -169.35 42.35 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.705 -0.76 . . . . 73.21 112.448 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -42.8 3.09 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.728 2.285 . . . . 72.21 112.297 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.808 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.9 mt -82.61 134.11 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 74.11 111.143 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.623 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.66 3.48 44.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 73.01 110.86 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.343 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.15 128.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 63.12 110.913 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.6 68.1 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 75.25 111.109 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.74 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.4 p90 -174.46 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.265 -0.425 . . . . 71.32 110.95 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.74 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.7 m -75.08 -33.07 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 61.02 111.149 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.12 41.47 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 64.13 111.171 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -120.12 -36.81 3.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 74.41 110.831 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.3 67.3 0.17 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.748 -0.739 . . . . 71.4 112.522 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -151.61 -175.46 5.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 72.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -139.74 -176.1 4.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.939 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.15 -35.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 63.21 110.918 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.53 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.741 -0.743 . . . . 61.44 112.484 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 1.339 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.498 -0.241 . . . . 64.32 112.498 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.0 -105.79 0.26 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 71.22 112.441 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.84 125.84 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.356 . . . . 72.22 110.866 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.95 -169.47 42.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 70.54 112.518 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -42.44 3.42 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.702 2.268 . . . . 73.12 112.333 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.807 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.0 mt -82.89 134.08 27.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 71.33 111.158 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.71 3.54 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 61.11 110.894 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.339 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.5 mt-10 72.23 128.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 55.01 110.908 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.1 p -109.49 68.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 71.02 111.129 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.739 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.4 p90 -174.49 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.442 . . . . 73.01 110.93 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.739 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.6 m -75.31 -33.03 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 71.44 111.125 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.19 41.38 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 44.32 111.156 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -119.83 -37.23 3.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 73.53 110.927 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.74 67.27 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.77 -0.729 . . . . 53.34 112.486 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -151.53 -175.35 5.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 62.23 110.842 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -139.78 -176.04 4.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 73.14 110.906 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.21 -35.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 65.34 110.863 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.517 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 75.13 112.485 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 1.346 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.489 -0.244 . . . . 45.03 112.489 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.3 -105.22 0.25 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.745 -0.74 . . . . 64.42 112.498 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -173.24 125.86 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 72.44 110.924 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.84 -169.33 42.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 72.11 112.52 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -42.7 3.13 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.658 2.239 . . . . 53.42 112.321 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.802 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.1 mt -82.64 134.14 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 74.13 111.148 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.65 3.43 44.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.13 110.86 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.346 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.14 128.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 72.02 110.877 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.4 p -109.57 68.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 63.22 111.173 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.737 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.49 -34.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 72.31 110.918 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.737 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.9 m -75.06 -32.95 27.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.436 . . . . 75.55 111.148 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.19 41.36 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 70.25 111.141 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -120.1 -37.02 3.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 74.4 110.9 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.48 67.1 0.16 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 71.31 112.469 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -151.16 -175.44 5.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 74.32 110.877 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.73 -176.19 4.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 65.33 110.982 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -171.99 -35.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.484 . . . . 70.32 110.939 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.519 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.71 -0.757 . . . . 65.31 112.464 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 1.348 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.484 -0.246 . . . . 65.44 112.484 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.63 -105.25 0.25 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.764 -0.731 . . . . 71.22 112.478 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.15 125.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 71.05 110.89 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.91 -169.34 42.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 54.31 112.498 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -42.77 3.11 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 43.11 112.351 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.803 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.3 mt -82.54 134.16 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.32 111.173 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.72 3.45 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 63.2 110.834 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.348 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.14 128.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 72.45 110.879 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.71 68.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 71.01 111.148 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.74 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.44 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 72.12 110.908 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.74 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.6 m -75.02 -33.09 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 71.53 111.131 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.21 41.36 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 64.24 111.167 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -120.22 -36.36 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 71.34 110.838 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 67.21 0.17 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.768 -0.73 . . . . 63.24 112.513 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -151.3 -175.44 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 54.34 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -139.83 -176.23 4.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 74.55 110.914 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.02 -35.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.12 110.922 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.519 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.722 -0.751 . . . . 65.52 112.492 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 1.349 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.488 -0.245 . . . . 60.41 112.488 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.18 -105.49 0.26 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.734 -0.746 . . . . 61.22 112.509 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -173.04 125.79 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 72.13 110.899 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.95 -169.33 42.37 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 74.21 112.514 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -42.65 3.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 72.43 112.313 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.3 mt -82.72 134.1 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.01 111.132 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.626 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.68 3.46 44.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.858 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.349 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.3 mt-10 72.17 128.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 71.0 110.931 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.48 68.2 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 74.43 111.149 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.743 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.48 -34.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 63.22 110.913 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.743 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.5 m -75.32 -32.99 26.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 64.32 111.147 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.28 41.27 0.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 75.44 111.141 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -119.8 -37.28 3.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 65.03 110.903 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.85 67.04 0.16 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 74.41 112.524 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -151.34 -175.43 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.827 0.346 . . . . 64.34 110.865 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -139.75 -176.13 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 71.54 110.888 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.01 -35.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 75.11 110.955 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.521 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 60.31 112.477 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 1.355 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.468 -0.253 . . . . 75.24 112.468 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.34 -105.4 0.25 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 41.32 112.496 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -173.09 125.82 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 73.5 110.893 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.9 -169.35 42.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.704 -0.76 . . . . 31.43 112.502 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -42.75 3.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.733 2.289 . . . . 74.34 112.363 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.786 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.3 mt -82.67 134.12 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 61.51 111.087 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.68 3.5 44.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 61.42 110.899 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.355 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.4 mt-10 72.19 128.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.25 110.883 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.54 68.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 75.45 111.113 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.736 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.53 -34.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.256 -0.429 . . . . 74.22 110.959 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.736 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.8 m -75.16 -32.98 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 71.13 111.138 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.16 41.43 0.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 64.33 111.147 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -120.16 -37.01 3.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 73.11 110.86 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.51 67.32 0.16 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.707 -0.759 . . . . 44.24 112.482 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -151.49 -175.39 5.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.887 0.375 . . . . 75.21 110.86 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -139.83 -176.15 4.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 73.23 110.918 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.07 -35.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 71.43 110.871 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.527 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.368 0 C-N-CA 120.768 -0.73 . . . . 55.24 112.485 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 1.342 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.473 -0.251 . . . . 51.42 112.473 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.41 -105.14 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 72.33 112.489 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.3 125.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.874 0.369 . . . . 71.41 110.863 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.81 -169.32 42.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 74.22 112.503 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -42.72 3.13 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.687 2.258 . . . . 71.32 112.379 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.1 mt -82.68 134.25 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 65.14 111.115 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.627 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.83 3.51 45.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 72.11 110.862 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.342 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.2 mt-10 72.14 128.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 65.32 110.922 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.67 68.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 75.53 111.129 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.739 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.3 p90 -174.45 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 75.21 110.905 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.739 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.8 m -75.0 -33.22 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 71.44 111.124 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 11' ' ' VAL . 8.8 t 38.25 41.38 0.41 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 62.44 111.103 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -120.3 -36.16 3.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.434 . . . . 72.44 110.872 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.67 67.74 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 62.41 112.538 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -151.95 -175.48 5.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 72.35 110.916 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -139.82 -176.24 4.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 70.21 110.901 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -171.97 -35.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 74.24 110.964 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.772 -0.728 . . . . 74.14 112.506 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 1.354 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.508 -0.237 . . . . 72.11 112.508 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.5 -104.95 0.24 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 71.32 112.52 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.37 125.93 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 63.21 110.92 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.83 -169.27 42.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 74.23 112.477 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -42.84 3.07 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.702 2.268 . . . . 65.5 112.355 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.798 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.7 mt -82.71 134.25 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 60.34 111.107 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.73 3.44 44.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 74.11 110.855 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.354 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.09 128.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 74.2 110.917 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.69 68.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 71.34 111.15 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.741 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.0 p90 -174.44 -34.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.933 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.741 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.6 m -75.15 -33.23 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 54.41 111.147 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.15 41.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 44.32 111.109 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.1 -36.48 3.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 64.44 110.895 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.1 67.74 0.17 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.744 -0.741 . . . . 60.2 112.495 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -152.26 -175.58 5.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 72.51 110.908 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -139.65 -176.02 4.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 75.51 110.927 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -172.04 -35.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.2 110.948 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.529 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 61.23 112.47 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 1.354 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.523 -0.231 . . . . 71.43 112.523 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.33 -105.44 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 73.42 112.468 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -173.12 125.77 0.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 74.02 110.893 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.89 -169.29 42.32 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.769 -0.729 . . . . 75.01 112.503 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -42.77 3.11 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.672 2.248 . . . . 74.14 112.347 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.795 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.1 mt -82.62 134.12 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 73.33 111.135 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.73 3.46 44.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 73.24 110.846 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.354 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.3 mt-10 72.23 128.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.94 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.54 68.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 64.0 111.111 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.739 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.2 p90 -174.5 -34.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.244 -0.434 . . . . 72.45 110.933 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.739 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.6 m -75.07 -33.14 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.144 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.14 41.48 0.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 62.21 111.137 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -120.29 -36.29 3.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 71.15 110.86 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 67.85 0.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.74 . . . . 53.05 112.474 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -152.17 -175.48 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 71.41 110.876 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -139.78 -176.11 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 74.35 110.905 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.1 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 70.45 110.954 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 72.02 112.473 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 1.352 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.452 -0.259 . . . . 64.43 112.452 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.55 -104.91 0.24 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.756 -0.735 . . . . 65.31 112.508 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -173.49 125.88 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 62.54 110.88 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.86 -169.19 42.23 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 74.52 112.484 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -42.89 3.0 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.73 2.287 . . . . 72.14 112.33 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.799 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.7 mt -82.71 134.29 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 73.2 111.131 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.622 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.77 3.44 45.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.922 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.352 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.2 mt-10 72.21 128.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 64.35 110.867 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.71 68.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 55.22 111.14 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.742 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.4 p90 -174.49 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 73.21 110.905 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.742 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.5 m -75.16 -33.31 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 74.35 111.118 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.17 41.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 73.23 111.131 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -120.03 -36.55 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 71.43 110.885 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.25 68.02 0.17 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.708 -0.758 . . . . 75.34 112.475 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -152.74 -175.69 5.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 64.52 110.854 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -139.54 -175.94 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 75.42 110.942 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.01 -35.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 73.42 110.922 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.529 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 51.2 112.514 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 1.343 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.469 -0.252 . . . . 75.52 112.469 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.44 -105.31 0.25 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 65.05 112.457 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.1 125.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 63.51 110.887 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.85 -169.35 42.35 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.705 -0.76 . . . . 73.21 112.448 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -42.8 3.09 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.728 2.285 . . . . 72.21 112.297 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.808 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.9 mt -82.61 134.11 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 74.11 111.143 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.623 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.66 3.48 44.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 73.01 110.86 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.343 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.1 mt-10 72.15 128.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 63.12 110.913 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -109.6 68.1 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 75.25 111.109 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.74 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.4 p90 -174.46 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.265 -0.425 . . . . 71.32 110.95 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.74 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.7 m -75.08 -33.07 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 61.02 111.149 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.12 41.47 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 64.13 111.171 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -120.12 -36.81 3.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 74.41 110.831 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.3 67.3 0.17 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.748 -0.739 . . . . 71.4 112.522 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -151.61 -175.46 5.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 72.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -139.74 -176.1 4.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.939 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.15 -35.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 63.21 110.918 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.53 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.741 -0.743 . . . . 61.44 112.484 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 1.339 ' N ' ' CD ' ' A' ' 8' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.498 -0.241 . . . . 64.32 112.498 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.0 -105.79 0.26 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 71.22 112.441 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.84 125.84 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.356 . . . . 72.22 110.866 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.95 -169.47 42.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 70.54 112.518 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -42.44 3.42 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.702 2.268 . . . . 73.12 112.333 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.807 HG22 ' H ' ' A' ' 8' ' ' GLU . 14.0 mt -82.89 134.08 27.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 71.33 111.158 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.621 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -86.71 3.54 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 61.11 110.894 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.339 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 26.5 mt-10 72.23 128.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 55.01 110.908 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.1 p -109.49 68.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 71.02 111.129 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.739 ' NE1' HG13 ' A' ' 11' ' ' VAL . 33.4 p90 -174.49 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.442 . . . . 73.01 110.93 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.739 HG13 ' NE1' ' A' ' 10' ' ' TRP . 4.6 m -75.31 -33.03 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 71.44 111.125 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t 38.19 41.38 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 44.32 111.156 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -119.83 -37.23 3.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 73.53 110.927 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.74 67.27 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.77 -0.729 . . . . 53.34 112.486 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -151.53 -175.35 5.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 62.23 110.842 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -139.78 -176.04 4.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 73.14 110.906 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.21 -35.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 65.34 110.863 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.517 ' C ' HD12 ' A' ' 6' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 75.13 112.485 179.926 . . . . . . . . 1 1 . 1 stop_ save_